Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Sales: 2016-2025

Historic Return on Sales for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -16.73%.

  • AC Immune's Return on Sales fell 1521.00% to -16.73% in Q3 2025 from the same period last year, while for Sep 2025 it was -16.73%, marking a year-over-year decrease of 1521.00%. This contributed to the annual value of -1.86% for FY2024, which is 180.00% up from last year.
  • Per AC Immune's latest filing, its Return on Sales stood at -16.73% for Q3 2025, which was down 831.33% from -1.80% recorded in Q2 2025.
  • AC Immune's Return on Sales' 5-year high stood at 165.37% during Q3 2021, with a 5-year trough of -210.99% in Q2 2024.
  • Its 3-year average for Return on Sales is -39.71%, with a median of -16.73% in 2025.
  • Per our database at Business Quant, AC Immune's Return on Sales slumped by 20,669bps in 2022 and then skyrocketed by 20,919bps in 2025.
  • Quarterly analysis of 5 years shows AC Immune's Return on Sales stood at 59.31% in 2021, then crashed by 9,104bps to -31.72% in 2022, then tumbled by 1,183bps to -43.55% in 2023, then spiked by 4,166bps to -1.89% in 2024, then tumbled by 1,521bps to -16.73% in 2025.
  • Its Return on Sales stands at -16.73% for Q3 2025, versus -1.80% for Q2 2025 and -1.89% for Q1 2025.